Sleep Apnea Scare: Philips Reaches $1.1 Billion Deal to Settle Lawsuits

The Netherlands-based medical device manufacturer, Philips, recently announced a $1.1 billion settlement in the United States to address lawsuits related to faulty sleep machines. The settlement comes after a series of issues with the company’s DreamStation machines, which are used to treat sleep apnea, a condition characterized by interrupted breathing during sleep. In response to the crisis, Philips halted new sales of the machines in the US earlier this year following recalls of devices made …

Read more

Sleep Apnea Breakthrough: Weight Loss Drug Zepbound Improves Symptoms, Prompts FDA Expansion Review by Eli Lilly

Indianapolis, IN – Eli Lilly and Company announced that their weight loss drug Zepbound may have additional benefits for individuals with obstructive sleep apnea. The drugmaker revealed that preliminary trials showed promising results, leading to plans to submit the findings to the US Food and Drug Administration for potential approval to use Zepbound in treating sleep apnea. Obstructive sleep apnea is a common disorder that causes breathing interruptions during sleep, affecting millions of people globally. …

Read more

Eli Lilly’s Revolutionary Weight-Loss Drug Reduces Sleep Apnea Symptoms, Study Shows

Indianapolis, IN – A recent study conducted by pharmaceutical company Eli Lilly has shown promising results in reducing sleep apnea in individuals who took a weight-loss drug. The drug, known as Zepbound, has demonstrated effectiveness in improving the condition of obstructive sleep apnea, a common disorder that affects breathing during sleep. The findings of the study have sparked interest in the medical community, as sleep apnea is a widespread issue that can lead to serious …

Read more

Weight Loss Drug Zepbound from Eli Lilly Shown to Significantly Reduce Sleep Apnea Events in Adults with Obesity

Indianapolis, IN – Eli Lilly’s weight loss drug, Zepbound, has shown promising results in reducing obstructive sleep apnea in adults with obesity, according to a recent announcement by the drugmaker. Obstructive sleep apnea, a condition affecting approximately 39 million adults in the U.S., occurs when a person’s upper airway becomes blocked during sleep, leading to disruptions in airflow throughout the night. The National Heart, Lung, and Blood Institute states that obesity, by narrowing the airway, …

Read more

Risk of Philips’ Sleep Apnea Machines Linked to Over 500 Deaths and Class Action Settlement

WASHINGTON, D.C. – The U.S. Food and Drug Administration (FDA) issued an update to a recall affecting millions of Philips sleep apnea machines, saying they may have been linked to at least 561 reported deaths. The FDA has received more than 116,000 reports about the respiratory devices since April 2021, finding that they have been found to break down and cause serious health hazards including choking, inhalation of foreign particles and increased risk of cancer. …

Read more